Find Reports
Select Report Type
Reimbursement Review
Displaying 776 - 800 of 1422
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| Interferon beta-1a | Rebif | Interferon beta-1a | Clinically isolated syndrome | Do not list | Complete | SR0298-000 | |||
| Perjeta for Metastatic Breast ... | Perjeta Herceptin Combo Pack | Pertuzumab | Metastatic Breast Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0018-000 | |||
| Xtandi for metastatic Castrati... | Xtandi | Enzalutamide | Metastatic Castration Resistant Prostate Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0023-000 | |||
| Abatacept | Orencia | Abatacept | Arthritis, rheumatoid | List with clinical criteria and/or conditions | Complete | SR0299-000 | |||
| Eculizumab | Soliris | Eculizumab | Hemolytic Uremic Syndrome, Atypical | Do not list | Complete | SR0304-000 | |||
| Adalimumab | Humira | Adalimumab | Arthritis, juvenile idiopathic | List with clinical criteria and/or conditions | Complete | SR0308-000 | |||
| Nebivolol | Bystolic | Nebivolol | Hypertension | Do not list at the submitted price | Complete | SR0307-000 | |||
| Dabigatran etexilate | Pradaxa | Dabigatran etexilate | Atrial fibrillation prevention of stroke and systemic embolism | List with clinical criteria and/or conditions | Complete | SF0320-000 | |||
| Rivaroxaban | Xarelto | Rivaroxaban | List with clinical criteria and/or conditions | Complete | SF0321-00 | ||||
| Tykerb Letrozole for Metastati... | Tykerb (in combination with Letrozole) | Lapatinib | Metastatic Breast Cancer | Do not reimburse | Complete | PC0019-000 | |||
| Telaprevir | Incivek | Telaprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SF0305-000 | |||
| Boceprevir | Victrelis | Boceprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SF0303-000 | |||
| Telaprevir | Incivek | Telaprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SF0311-000 | |||
| Boceprevir | Victrelis | Boceprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SF0312-000 | |||
| Palonosetron hydrochloride | Aloxi (injection) | Palonosetron hydrochloride | Chemotherapy-induced nausea and vomiting | Do not list at the submitted price | Complete | SR0293-000 | |||
| Elvitegravir/ Cobicistat/ Em... | Stribild | Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Disoproxil Fumarate | HIV infection | List with criteria/condition | Complete | SR0301-000 | |||
| Glycopyrronium bromide | Seebri | Glycopyrronium bromide | Chronic obstructive pulmonary disease | List with criteria/condition | Complete | SR0300-000 | |||
| Xalkori for Advanced NSCLC - R... | Xalkori | Crizotinib | Advanced or Metastatic Non-Small Cell Lung Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0017-000 | |||
| Palonosetron hydrochloride | Aloxi (capsule) | Palonosetron hydrochloride | Chemotherapy-induced nausea and vomiting | Do not list | Complete | SR0294-000 | |||
| Pirfenidone | Esbriet | Pirfenidone | Idiopathic pulmonary fibrosis | Do not list | Complete | SR0292-000 | |||
| Collagenase clostridium histol... | Xiaflex | Collagenase clostridium histolyticum | Dupuytren’s contracture | List with criteria/condition | Complete | SR0287-000 | |||
| Doxycycline monohydrate | Apprilon | Doxycycline monohydrate | Rosacea | Do not list | Complete | SR0279-000 | |||
| Afinitor for Advanced Breast -... | Afinitor | Everolimus | Advanced Breast Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0014-000 | |||
| Velcade for Multiple Myeloma -... | Velcade | Bortezomib | Multiple Myeloma | Reimburse | Complete | PC0016-000 | |||
| Ivacaftor | Kalydeco | Ivacaftor | Cystic fibrosis, G551D mutation | List with criteria/condition | Complete | SR0291-000 |
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 776 - 800 of 2132
Please scroll or swipe to the right to view the full content.
| Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
|---|---|---|---|---|---|---|---|
| elexacaftor/tezacaftor/ivacaftor and ivacaftor | Reimbursement Review | Complete | SR0710-000 | ||||
| zanubrutinib | Reimbursement Review | Complete | PC0267-000 | ||||
| Mepivacaine Versus Bupivacaine for Patients Undergoing Total Joint Arthroplasty | Health Technology Review | Rapid Review | Completed | RC1453-000 | |||
| Vagus Nerve Stimulation for the Treatment of Post–COVID-19 Condition | Horizon Scan | Health Technology Update | Active | EN0040-000 | |||
| Therapeutic Support for Pressure Injuries | Health Technology Review | Rapid Review | Completed | RC1450-000 | |||
| Airway Pressure Release Ventilation for Acute Respiratory Distress Syndrome: An Update | Health Technology Review | Rapid Review | Completed | RC1451-000 | |||
| cenegermin | Reimbursement Review | Complete | SR0704-000 | ||||
| avalglucosidase alfa | Reimbursement Review | Complete | SR0703-000 | ||||
| Antiviral Prophylaxis With Tenofovir for Patients With History of Hepatitis B Receiving Oncology Drug Treatment | Health Technology Review | Rapid Review | Completed | RC1448-000 | |||
| RWE Learning Project Non-Oncology: Ocaliva | Health Technology Review | Technology Review | In Progress | HC0046-000 | |||
| Renal Cell Carcinoma (RCC) | Reimbursement Review | Provisional Funding Algorithm | Complete | PH0013-000 | |||
| tirzepatide | Reimbursement Review | Cancelled | SR0751-000 | ||||
| Considerations for the use of COVID-19 Rapid Tests | Health Technology Review | Environmental Scan | Completed | ES0364-000 | |||
| Utilization of Glucagon-Like Peptide-1 Receptor Agonists | Health Technology Review | Technology Review | Completed | HC0042-000 | |||
| CADTH Pharmaceutical Reviews Update — Issue 31 | Reimbursement Review | Pharmaceutical Review Update | |||||
| cemiplimab | Reimbursement Review | Complete | PC0262-000 | ||||
| amifampridine phosphate | Reimbursement Review | Complete | SR0664-000 | ||||
| tafamidis | Reimbursement Review | Complete | SF0722-000 | ||||
| Real-Time Continuous Glucose Monitoring for People Living With Type 1 Diabetes | Health Technology Review | Rapid Review | Completed | RC1442-000 | |||
| Health Technology Assessment Recommendations and Managed Entry Agreements Related to Optimizing the Treatment for Pediatric Spinal Muscular Atrophy | Health Technology Review | Environmental Scan | In Progress | ES0368-000 | |||
| Virtual Care Use in Primary Care or Specialty Care Settings | Health Technology Review | Rapid Review | Completed | RC1444-000 | |||
| Concurrent or Sequential Administration of Drugs for COVID-19 and Influenza | Health Technology Review | Rapid Review | Completed | RC1446-000 | |||
| Liposuction for Lipedema: A 2022 Update | Health Technology Review | Rapid Review | Completed | RC1447-000 | |||
| ospemifene | Reimbursement Review | Complete | SR0709-000 | ||||
| Mesalamine for the Treatment of Crohn Disease | Health Technology Review | Rapid Review | Completed | RC1445-000 |